Skip to main content
SpringerLink
Log in

New Developments in Pricing and Drug Reimbursement in France

  • Published:
PharmacoEconomics Aims and scope Submit manuscript

Summary

In this article, we review the current French price reimbursement scheme and how this scheme is affected by a new decree published in 1993, or will be affected by this decision already announced but not yet implemented.

France has been perceived as a pioneering country regarding the attitude of the Health Authority towards pharmacoeconomics. Here, we describe the present status afforded such studies in the price reimbursement scheme.

Finally, we discuss the possible impact of the national agreement between physicians and statutory Health Funds on the pharmaceutical industry in France.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Ministère des Affaires Sociales, de la Santé et de la Ville. Comptes Nationaux de la Santé-Paris, 1992

    Google Scholar 

  2. Raynaud J. Rapport sur le budget de l’Etat et les comptes sociaux. Le Monde, Mai, 1993; 16–18

    Google Scholar 

  3. Avouac B. L’évaluation du service médical rendur — une nécessité pour la commission de transparence. Thérapie 1992; 47: 9–16

    PubMed  CAS  Google Scholar 

  4. Décret du 29 mars 1993, J.O de la République Française, 5675, 1993

  5. LesEchos. 30 Jun, 1993

  6. Schwartz D. Connaissance et décisionou attitude explicative et attitude pragmatique. Encycl. Med. Chir. Paris, France, Hygiène et législation, 16900 A 10 1-1986

  7. Ministère des Affaires Sociales, de la Santé et de la Ville. Plan de redressement de l’assurance-maladie-dossier de press, Paris, June, 1993

  8. Official Journal of the French Republic. 5 January, 1993; 237-246; Low 93.5, 4 January, 1993

  9. Références médicales: 24 thèmes retenus. Le Quotidien du Médecin 1993; 5230: 3

  10. Hurst JW. Reforming Health care in seven European nations. Health Affairs 1991; 10 (3): 7–21

    Article  PubMed  CAS  Google Scholar 

  11. Degain J. Medicaments: esquisser une politique de prix. Le Quotidien du Medecin 1993; 5238: 4

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. IMS Health Economics, 85, rue Gabriel Peri, 92542, Montrouge Cedex Paris, France

    Alain Pelc

  2. Carré Castan Consultants, Paris, France

    Jean-Philippe Castan

Authors
  1. Alain Pelc
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jean-Philippe Castan
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pelc, A., Castan, JP. New Developments in Pricing and Drug Reimbursement in France. Pharmacoeconomics 6 (Suppl 1), 28–35 (1994). https://doi.org/10.2165/00019053-199400061-00009

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00019053-199400061-00009

Keywords

Search

Navigation